How to Start PDE5 Inhibitors in a 46-Year-Old Man with Erectile Dysfunction
First-Line Recommendation
Start with any FDA-approved PDE5 inhibitor (sildenafil, tadalafil, vardenafil, or avanafil) as first-line therapy after confirming the patient is not taking nitrates and has acceptable cardiovascular risk. 1, 2
Critical Safety Screening Before Prescribing
Absolute Contraindication
- Verify the patient is NOT taking nitrates in any form (sublingual nitroglycerin, long-acting nitrates, or recreational "poppers") due to risk of potentially fatal hypotension. 2, 3
Cardiovascular Risk Stratification
- Ask if the patient can walk 1 mile in 20 minutes or climb 2 flights of stairs without symptoms. If unable, refer to cardiology before prescribing. 2
Low-risk patients (safe to prescribe): 2, 3
- Asymptomatic coronary artery disease with <3 risk factors
- Controlled hypertension
- Mild, stable angina
- Successful coronary revascularization
- Uncomplicated prior MI
- Mild valvular disease
- CHF (NYHA class I)
High-risk patients (defer treatment until cardiac stabilization): 2, 3
- Unstable or refractory angina
- Uncontrolled hypertension
- Left ventricular dysfunction/CHF (NYHA ≥ II)
- MI or stroke within past 2 weeks
- High-risk arrhythmias
- Hypertrophic obstructive cardiomyopathy
- Moderate-to-severe valvular disease
Choosing the Specific PDE5 Inhibitor
All four FDA-approved PDE5 inhibitors have equivalent efficacy (~69% success vs 33% placebo), so selection depends on patient preference for timing and side effect profile. 2, 3
Tadalafil (Recommended for This Patient)
- Start with tadalafil 10 mg as-needed, taken 30-60 minutes before sexual activity. 1, 2
- Effective for up to 36 hours, allowing spontaneous sexual activity without precise timing. 2
- Alternative: tadalafil 2.5-5 mg once daily eliminates the need to time medication entirely. 2
- Lowest rates of flushing among PDE5 inhibitors. 2
- Note: Tadalafil does NOT show dose-dependent improvement between 5 mg, 10 mg, and 20 mg—dose escalation is based on tolerability, not expecting dramatically better efficacy. 2
Sildenafil (Alternative Option)
- Start with sildenafil 50 mg as-needed, taken 1 hour before sexual activity. 2
- Effective for 4-6 hours. 2
- Preferred when shorter nitrate-free interval is needed (24 hours vs 48 hours for tadalafil). 2
Vardenafil or Avanafil
- Both show dose-dependent efficacy and intermediate duration of action. 2
- Avanafil has lowest rates of dyspepsia. 4
Critical Patient Education for Treatment Success
An adequate trial requires at least 5 separate attempts at the prescribed dose before declaring treatment failure. 2, 5
Essential Instructions to Prevent Treatment Failure
- Sexual stimulation is REQUIRED—PDE5 inhibitors enhance but do not replace natural arousal. 2, 3
- Avoid taking with large or fatty meals, which reduce efficacy. 2
- Limit alcohol consumption—heavy alcohol impairs erectile function independent of medication. 2
- Timing matters: Take sildenafil 1 hour before, tadalafil 30-60 minutes before (or use daily dosing). 2
Up to 30% of apparent non-responders become successful responders with proper education and technique. 2
Baseline Laboratory Testing
Obtain the following labs if not assessed in the last 12 months: 1
- Fasting glucose and lipid profile
- Morning total testosterone (if <300 ng/dL, check free testosterone and SHBG)
Rationale: Men with testosterone deficiency respond less robustly to PDE5 inhibitors alone; combining tadalafil with testosterone therapy may be more effective than tadalafil alone in hypogonadal men. 2
Dose Titration Strategy
When to Increase Dose
Increase to maximum dose (tadalafil 20 mg as-needed or sildenafil 100 mg) when: 2
- Patient has completed at least 5 attempts at current dose with proper technique
- Erectile function remains suboptimal
- Current dose is well-tolerated
- All modifiable factors have been addressed (see below)
Before Escalating Dose, Address These Modifiable Factors
Systematically evaluate and correct: 2, 5
- Hormonal abnormalities: Check testosterone if not already done
- Heavy alcohol use: Impairs erectile function independent of medication
- Inadequate sexual stimulation: PDE5 inhibitors require arousal
- Large meals: Taking medication with substantial food reduces efficacy
- Relationship issues: Psychological factors significantly impact response
- Concomitant medications: Review for drugs that impair erectile function (antihypertensives, antidepressants, opioids)
When to Switch to Another PDE5 Inhibitor
Switch to a different PDE5 inhibitor only after: 2, 5
- Completing maximum-dose regimen (tadalafil 20 mg or sildenafil 100 mg) for at least 5 attempts
- All modifiable factors have been addressed
- Testosterone supplementation has been evaluated if levels are low
Approximately 60% of patients who fail one PDE5 inhibitor achieve successful response with another. 5
Second-Line Therapies (After Failure of Two PDE5 Inhibitors at Maximum Dose)
Proceed to second-line options only after failure of at least two different PDE5 inhibitors at maximum dose with proper technique: 2
- Vacuum erection device: Non-pharmacologic, no systemic side effects 2
- Intracavernosal injection therapy (alprostadil, papaverine, phentolamine): Most effective non-surgical option, highest priapism risk 2
- Intraurethral alprostadil suppositories: Less effective than injections but less invasive; first administration should be supervised due to ~3% syncope risk 2
- Penile prosthesis implantation: Definitive surgical solution for refractory cases 2
Common Side Effects and Management
Most common adverse events: 1, 2
- Dyspepsia
- Headache
- Back pain
- Nasal congestion
- Myalgia
Higher doses increase adverse events in a dose-dependent manner, particularly dyspepsia, headache, back pain, myalgia, and flushing. 2
Emergency Nitrate Protocol
If patient requires emergency nitrate administration: 2
- Wait 24 hours after sildenafil or vardenafil
- Wait 48 hours after tadalafil
- Administer under close medical supervision with continuous monitoring
Follow-Up Schedule
Periodic follow-up should assess: 2, 3
- Treatment effectiveness and patient satisfaction
- Side effects and tolerability
- Changes in cardiovascular health status
- New medications that may interact or impair erectile function
- Relationship dynamics and psychosocial factors
Special Considerations for This 46-Year-Old Patient
Loss of morning erections suggests organic (vascular/hormonal) rather than purely psychogenic ED. 1
Check morning testosterone level—if low, combining PDE5 inhibitor with testosterone therapy may be more effective than PDE5 inhibitor alone. 2
At age 46 with new-onset ED, assess cardiovascular risk factors (hypertension, diabetes, hyperlipidemia, smoking) as ED often precedes cardiovascular disease by 3-5 years. 1